Telomere stability genes are not mutated in osteosarcoma cell lines

Cancer Genetics and Cytogenetics

Volumn 160, Issue 1, 2005, Pages 79-81

  Savage, Sharon A ^a   Stewart, Brian J ^a   Liao, Jason S ^a   Helman, Lee J ^a   Chanock, Stephen J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RAP PROTEIN; TANKYRASE; TELOMERASE; TELOMERIC REPEAT BINDING FACTOR 1; TELOMERIC REPEAT BINDING FACTOR 2;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; EXON; GENE MUTATION; GENE TARGETING; GENETIC ANALYSIS; GENETIC STABILITY; GERM LINE; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS; SOMATIC MUTATION; TELOMERE;

BONE NEOPLASMS; CELL LINE, TUMOR; HUMANS; MUTATION; OSTEOSARCOMA; POLYMORPHISM, SINGLE NUCLEOTIDE; TELOMERASE; TELOMERE; TELOMERIC REPEAT BINDING PROTEIN 1; TELOMERIC REPEAT BINDING PROTEIN 2;

EID: 20444376924     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2004.12.004     Document Type: Article

References (31)

1. D.M. Parkin, C.A. Stiller, G.J. Draper, and C.A. Bieber The international incidence of childhood cancer Int J Cancer 42 1988 511 520
2. J.C. Wittig, J. Bickels, D. Priebat, J. Jelinek, K. Kellar-Graney, B. Shmookler, and M.M. Malawer Osteosarcoma: a multidisciplinary approach to diagnosis and treatment Am Fam Physician 65 2002 1123 1132
3. B. Fuchs, and D.J. Pritchard Etiology of osteosarcoma Clin Orthop 397 2002 40 52
4. A.A. Sandberg, and J.A. Bridge Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors Cancer Genet Cytogenet 145 2003 1 30
5. T. Ozaki, K.L. Schaefer, D. Wai, H. Buerger, S. Flege, N. Lindner, M. Kevric, R. Diallo, A. Bankfalvi, C. Brinkschmidt, H. Juergens, W. Winkelmann, B. Dockhorn-Dworniczak, S.S. Bielack, and C. Poremba Genetic imbalances revealed by comparative genomic hybridization in osteosarcomas Int J Cancer 102 2002 355 365
6. R. Dagher, T.A. Pham, L. Sorbara, S. Kumar, L. Long, D. Bernstein, C. Mackall, M. Raffeld, M. Tsokos, and L. Helman Molecular confirmation of Ewing sarcoma J Pediatr Hematol Oncol 23 2001 221 224
7. K. Collins, and J.R. Mitchell Telomerase in the human organism Oncogene 21 2002 564 579
8. R.S. Maser, and R.A. DePinho Connecting chromosomes, crisis, and cancer Science 297 2002 565 569
9. J.W. Shay, and S. Bacchetti A survey of telomerase activity in human cancer Eur J Cancer 33 1997 787 791
10. C. Scheel, and C. Poremba Telomere lengthening in telomerase-negative cells: the ends are coming together Virchows Arch 440 2002 573 582
11. C. Scheel, K.L. Schaefer, A. Jauch, M. Keller, D. Wai, C. Brinkschmidt, F. van Valen, W. Boecker, B. Dockhorn-Dworniczak, and C. Poremba Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas Oncogene 20 2001 3835 3844
12. R.P. Sanders, R. Drissi, C.A. Billups, N.C. Daw, M.B. Valentine, and J.S. Dome Telomerase expression predicts unfavorable outcome in osteosarcoma J Clin Oncol 22 2004 3790 3797
13. G.A. Ulaner, H.Y. Huang, J. Otero, Z. Zhao, L. Ben Porat, J.M. Satagopan, R. Gorlick, P. Meyers, J.H. Healey, A.G. Huvos, A.R. Hoffman, and M. Ladanyi Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma Cancer Res 63 2003 1759 1763
14. A. Smogorzewska, and T. de Lange Regulation of telomerase by telomeric proteins Ann Rev Biochem 73 2004 177 208
15. W.N. Keith, A. Bilsland, T.R. Evans, and R.M. Glasspool Telomerase-directed molecular therapeutics Expert Rev Mol Med 2002 2002 1 25
16. L. Chong, B. van Steensel, D. Broccoli, H. Erdjument-Bromage, J. Hanish, P. Tempst, and T. de Lange A human telomeric protein Science 270 1995 1663 1667
17. D. Broccoli, A. Smogorzewska, L. Chong, and T. de Lange Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2 Nat Genet 17 1997 231 235
18. P. Baumann, and T.R. Cech Pot1, the putative telomere end-binding protein in fission yeast and humans Science 292 2001 1171 1175
19. B. van Steensel, A. Smogorzewska, and T. de Lange TRF2 protects human telomeres from end-to-end fusions Cell 92 1998 401 413
20. J. Karlseder, A. Smogorzewska, and T. de Lange Senescence induced by altered telomere state, not telomere loss Science 295 2002 2446 2449
21. S.M. Bailey, M.N. Cornforth, A. Kurimasa, D.J. Chen, and E.H. Goodwin Strand-specific postreplicative processing of mammalian telomeres Science 293 2001 2462 2465
22. A. Smogorzewska, B. van Steensel, A. Bianchi, S. Oelmann, M.R. Schaefer, G. Schnapp, and T. de Lange Control of human telomere length by TRF1 and TRF2 Mol Cell Biol 20 2000 1659 1668
23. S.H. Kim, P. Kaminker, and J. Campisi TIN2, a new regulator of telomere length in human cells Nat Genet 23 1999 405 412
24. S. Smith, I. Giriat, A. Schmitt, and T. de Lange Tankyrase, a poly(ADP-ribose) polymerase at human telomeres Science 282 1998 1484 1487
25. D. Loayza, and T. de Lange POT1 as a terminal transducer of TRF1 telomere length control Nature 424 2003 1013 1018
26. B. Li, S. Oestreich, and T. de Lange Identification of human Rap1: implications for telomere evolution Cell 101 2000 471 483
27. B. Li, and T. de Lange Rap1 affects the length and heterogeneity of human telomeres Mol Biol Cell 14 2003 5060 5068
28. B.R. Packer, M. Yeager, B. Staats, R. Welch, A. Crenshaw, M. Kiley, A. Eckert, M. Beerman, E. Miller, A. Bergen, N. Rothman, R. Strausberg, and S.J. Chanock SNP500Cancer: a public resource for sequence validation and assay development for genetic variation in candidate genes Nucleic Acids Res 32 2004 Database issue:D528-32
29. L. Kruglyak, and D.A. Nickerson Variation is the spice of life Nat Genet 27 2001 234 236
30. T.M. Bryan, A. Englezou, L. Dalla-Pozza, M.A. Dunham, and R.R. Reddel Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines Nat Med 3 1997 1271 1274
31. T.R. Yeager, A.A. Neumann, A. Englezou, L.I. Huschtscha, J.R. Noble, and R.R. Reddel Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body Cancer Res 59 1999 4175 4179